A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Subjects will receive POM-X or placebo pills daily for up to 4 weeks prior to undergoing
radical prostatectomy for prostate cancer. Biomarkers in the blood, urine, and prostate
tissue will be assessed.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Pomegranate oxidative stress
On day of prostate surgery following 4 weeks of taking POM-X or placebo.
Allan J Pantuck, MD
University of California, Los Angeles
United States: Institutional Review Board
|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins||Baltimore, Maryland 21231-2410|
|Duke University Medical Center||Durham, North Carolina 27710|
|UCLA||Los Angeles, California 90095|